000 | 01698 a2200481 4500 | ||
---|---|---|---|
005 | 20250517160544.0 | ||
264 | 0 | _c20190225 | |
008 | 201902s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/s41598-017-03443-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Po-Sheng | |
245 | 0 | 0 |
_aRecombinant Thrombomodulin Exerts Anti-autophagic Action in Endothelial Cells and Provides Anti-atherosclerosis Effect in Apolipoprotein E Deficient Mice. _h[electronic resource] |
260 |
_bScientific reports _c06 2017 |
||
300 |
_a3284 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApolipoproteins E _xdeficiency |
650 | 0 | 4 |
_aAtherosclerosis _xdrug therapy |
650 | 0 | 4 |
_aAutophagy _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 1 _xmetabolism |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aStress, Physiological |
650 | 0 | 4 |
_aThrombomodulin _xmetabolism |
700 | 1 | _aWang, Kuan-Chieh | |
700 | 1 | _aChao, Ting-Hsing | |
700 | 1 | _aChung, Hsing-Chun | |
700 | 1 | _aTseng, Shi-Ya | |
700 | 1 | _aLuo, Chawn-Yau | |
700 | 1 | _aShi, Guey-Yueh | |
700 | 1 | _aWu, Hua-Lin | |
700 | 1 | _aLi, Yi-Heng | |
773 | 0 |
_tScientific reports _gvol. 7 _gno. 1 _gp. 3284 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-017-03443-z _zAvailable from publisher's website |
999 |
_c27270958 _d27270958 |